MiR‐378a‐3p as a putative biomarker for hepatocellular carcinoma diagnosis and prognosis: Computational screening with experimental validation

BACKGROUND: Hepatocellular carcinoma (HCC) is a malignant disease with high morbidity and mortality, and the molecular mechanism for the genesis and progression is complex and heterogeneous. Biomarker discovery is crucial for the personalized and precision treatment of HCC. The accumulation of repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Fuliang, Wang, Jinghan, Wang, Ying, Gao, Qian, Yan, Wenying, Lin, Yuxin, Shen, Li, Xie, Yufeng, Jiang, Xiaoqing, Shen, Bairong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882078/
https://www.ncbi.nlm.nih.gov/pubmed/33634974
http://dx.doi.org/10.1002/ctm2.307

Ejemplares similares

Ejemplares similares